| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Finding the Right Way to Motivate Your Employees |
|
Main Subject - Finding the Right Way to Motivate Your Employees
Fear, Incentives and Growth Zig Ziglar says that there are three main ways to motivate people in general and employ According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ees specifically. They are fear, incentives and growth. Let's take a look at each one. Fear. This is not good. Numb ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in er one, it isn't right, and number two, it doesn't work well in the long run and isn't good for the overall health o lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. f the organization. Yet, still there are people who use it. They make blatant or veiled threats in order to get peop here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e to work. There is a better way. Incentives. John Maxwell says that "What gets rewarded, gets done." This is the t d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro echnique that says, "If you do this, then you will get this." The problem Ziglar sees, and I concur, is that people ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc will be led this way for a while, and it will surely be profitable and productive. Yet eventually, most people come easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi to the end of being driven by incentive. This is because most people are innately driven by something even deeper. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically rowth. Personal growth. Do you ever wonder how the personal growth industry has gotten so huge? It is because it scr and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ atches an itch that lies within each person. Every person has within them, a desire to get better. Now, obviously, s ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ome are more in tune with that desire than others, but each person has it, and it can a great motivating factor. Fi ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a rst, here is how it doesn't work. You don't say "If you do this, then I will give you a personal growth opportunity. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod That is still incentive. Here is how it does work: You simply make it a core value of your business or organizatio cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin n that management will give regular opportunity for personal and professional growth to all members of the staff. I tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen say both personal and professional growth very purposely. There will always be the opportunity and need for profess t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ional growth, and the employees expect that. They may or may not appreciate it though. However, personal growth opp ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust rtunities, given with no strings attached, will be appreciated, and rewarded with ultra-motivated employees. Here ar y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products e some simple ideas: A "Family Library" stocked with books and tapes that help them in their family life. A Financ . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ial Resources section. Any kind of Development Seminar that will benefit the employee. Days off to pursue personal elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip development opportunities. Invest in your employee's personal growth and they will reward you with high motivation tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Six Sigma Mis-Implementation: How to Know if You're a Victim, Before It's Too Late! Successful Organizational Leadership: Effective Execution through Strategic Alignment
|